TheraRadar
Clinical-Stage Companies / Ethicon

Ethicon

Pre-Approval PRO BETA
đź”´

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 4/16/2018

19
Total Trials
11
Phase 3
4
Phase 2
0
Recruiting
200
Score

Pipeline by Phase

Phase 3
11
Phase 2
4
Phase 1
1

Therapeutic Focus

Hemorrhage Soft Tissue Bleeding Cardiovascular Disease Hemostasis Controlling Mild to Moderate Bleeding During Surgery

Clinical Trials (19)

NCT03255174 Phase 3 COMPLETED

The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study

Started: 3/20/2018

NCT02227992 Phase 3 COMPLETED

The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study

Started: 7/1/2014

NCT02309645 Phase 3 TERMINATED

The Paediatric EVICEL® Neuro Study

Started: 10/1/2014

NCT03462563 Phase 3 TERMINATED

Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™

Started: 4/16/2018

NCT02227706 Phase 3 COMPLETED

The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study

Started: 8/1/2014

NCT02457546 Phase 3 COMPLETED

The EVICEL® Neurosurgery Phase III Study

Started: 7/1/2015

NCT02040428 Phase 3 COMPLETED

The Fibrin Pad CV Phase III Study

Started: 1/1/2014

NCT01993888 Phase 3 COMPLETED

The EVARREST® Fibrin Sealant Patch Liver Study

Started: 10/1/2013

NCT00977925 Phase 3 COMPLETED

The Severe Soft Tissue Bleeding Study

Started: 8/1/2009

NCT01166243 Phase 3 COMPLETED

The Fibrin Pad Liver Study

Started: 7/1/2010

NCT01681030 Phase 2 COMPLETED

The Fibrin Pad Cardiovascular Study

Started: 8/1/2012

NCT01589822 Phase 2 COMPLETED

The EVICEL® Gastrointestinal Study

Started: 6/1/2012

NCT00658723 Phase 2 COMPLETED

The Fibrin Patch Soft Tissue Study

Started: 3/1/2008

NCT01174992 Phase 2 COMPLETED

A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair

Started: 7/1/2010

NCT01855672 Phase 1 TERMINATED

Occipital Nerve Stimulation in the Treatment of Migraine

Started: 4/1/2013

NCT02094885 Phase 4 COMPLETED

The Bioseal Vascular Study

Started: 2/1/2014

NCT02034799 Phase 4 COMPLETED

Phase IV Bioseal Study in Brain Tumor Surgery

Started: 11/1/2013

NCT01902459 Phase 4 COMPLETED

EVARREST™ Fibrin Sealant Patch Post-Market Study

Started: 7/1/2013

NCT00768222 Phase 4 COMPLETED

Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery

Started: 10/1/2008

Drug Candidates

EVARREST® Fibrin Sealant Patch EVARREST™ Sealant Matrix EVICEL® Fibrin Sealant EVICEL Fibrin Sealant EVARREST™ Topical hemostat Bioseal Fibrin Sealant EVARREST™ Fibrin Sealant Patch Fibrin Pad Evicel
Activity Status: Stale
Last Trial Started: 4/16/2018
Last Trial Ended: 2/14/2025
Trials (12 months): 0
Completed Trials: 16
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.